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While	the	thymus	is	known	to	be	essential	for	the	initial	production	of	T	cells	during	early	life,	its	contribution	
to	immune	development	remains	a	matter	of	debate.	In	fact,	during	cardiac	surgery	in	newborns,	the	thymus	
is	completely	resected	to	enable	better	access	to	the	heart	to	correct	congenital	heart	defects,	suggesting	that	it	
may	be	dispensable	during	childhood	and	adulthood.	Here,	we	show	that	young	adults	thymectomized	during	
early	childhood	exhibit	an	altered	T	cell	compartment.	Specifically,	absolute	CD4+	and	CD8+	T	cell	counts	were	
decreased,	and	these	T	cell	populations	showed	substantial	loss	of	naive	cells	and	accumulation	of	oligoclonal	
memory	cells.	A	subgroup	of	these	young	patients	(22	years	old)	exhibited	a	particularly	altered	T	cell	profile	
that	is	usually	seen	in	elderly	individuals	(more	than	75	years	old).	This	condition	was	directly	related	to	CMV	
infection	and	the	induction	of	strong	CMV-specific	T	cell	responses,	which	may	exhaust	the	naive	T	cell	pool	
in	the	absence	of	adequate	T	cell	renewal	from	the	thymus.	Together,	these	marked	immunological	alterations	
are	reminiscent	of	the	immune	risk	phenotype,	which	is	defined	by	a	cluster	of	immune	markers	predictive	of	
increased	mortality	in	the	elderly.	Overall,	our	data	highlight	the	importance	of	the	thymus	in	maintaining	the	
integrity	of	T	cell	immunity	during	adult	life.
Introduction
The thymus is the major production site of T cells, whose stocks are 
built up during fetal and early postnatal life. However, its function 
diminishes after the first years of life, and although thymic output 
is maintained into adulthood (1), the thymus mostly degenerates 
into fatty tissue in elderly adults (2). To date, there has been no gen-
eral consensus with regard to the importance of this organ during 
childhood and adulthood. As a consequence, its necessity beyond 
the initial production of T cells might be disregarded. In fact, open 
heart surgery to correct congenital heart defect (CHD) usually 
implies complete resection of the thymus. CHD is one of the most 
common defects at birth. It is estimated that 1 of every 100 babies 
is born with a CHD (3), so approximately 40,000 newborns may 
be affected in the United States each year. Of the dozens of CHDs 
(including septal defects, defects causing obstruction in the heart 
or blood vessels, cyanotic defects, or even complex abnormalities), 
some are mild and may need little or no medical treatment even 
through adulthood, however some defects are life threatening, 
either immediately to the newborn or over time. Up to 50% of all 
children born with a CHD require invasive surgery to correct the 
defect. Over the last 20 to 30 years, open heart surgery in newborns 
has become increasingly safe and has been performed more often. 
However, surgical access to the heart and great vessels is obstructed 
by the thymus, which occupies a large space within newborns and 
is therefore removed during the intervention.
Although there has been no report of clinical indications of immu-
nodeficiency in thymectomized CHD patients (such as higher infec-
tion rates) (4, 5), young adults thymectomized during early childhood 
(YATECs) represent a particularly informative group in evaluation of 
the importance of the thymus beyond the production of the initial 
T cell stock and in studying the long-term consequences of early 
thymectomy in adult life. Previous short-term surveys showed that 
thymectomized children have reduced CD4+ T cell and TCR excision 
circle numbers compared with age-matched controls (6–10). More 
recently, reduction of naive CD4+ T cell numbers and production in 
thymectomized patients was shown to correlate with chronological 
age and time since thymectomy (11). In order to examine the long-
term consequences of thymectomy on T cell population integrity, we 
studied quantitative and qualitative T cell attributes (i.e., CD4 and 
CD8 T cell counts and subset distributions, antigen-specific T cell 
functionality, TCR repertoire, proinflammatory cytokine profile) of 
25 young adults (18–26 years old) who were thymectomized during 
cardiac surgery shortly after birth. These donors were selected for 
being born with a transposition of the great vessels, which results 
in insufficiently oxygenated blood pumped to the body and leads to 
cyanosis (blue discoloration of the skin) and shortness of breath. Cor-
rection of this serious CHD therefore required heart surgery within 
2 weeks of birth. The immune characteristics of these donors were 
studied in comparison with age-matched, middle-aged, and elderly 
controls. Our data reveal that such YATECs present characteristic 
signs of a prematurely aged immune system. A subgroup of donors 
presented exacerbated alterations, which appeared to be associated 
with the development of an immune response against CMV.
Results
Altered T cell profile in YATECs.	Access to the great vessels for switch-
ing during open heart surgery usually involves total resection of 
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the thymus. Even if residual cervical extensions and regeneration 
of thymic tissue in YATECs cannot be excluded, a substantial 
reduction of the thymic mass is evident for the years following the 
intervention. This is particularly obvious during childhood, when 
the thymus ordinarily occupies a large volume (Figure 1). Analysis 
of PBMC samples from YATECs, taken an average of 2 decades 
after thymectomy, revealed clear alterations in the CD4+ T cell 
compartment (as expected from previous studies on CHD patients; 
ref. 6–11) as well as in the CD8+ T cell compartment. We found 
decreased CD4+ and CD8+ T cell counts in YATECs compared 
with age-matched controls, and even compared with middle-aged 
adult controls (Figure 2A). In contrast, counts of NK cells, which 
do not undergo thymic education, were not significantly different. 
In line with a lower thymic output, YATECs displayed significant 
reductions in the proportions of naive CD4+ and CD8+ T cells (i.e., 
characterized by a CD45RA+CCR7+CD27+ phenotype) (Figure 2B) 
along with lower CD31 expression (known to correlate with the 
TCR excision circle content in CD4+ T cells) (12, 13) within the 
naive CD4+ T cell compartment of these donors (Figure 2C).
We next looked at CD57, whose expression identifies highly dif-
ferentiated memory CD4+ and CD8+ T cells with shorter telomere 
length and reduced capacity to proliferate (reviewed in ref. 14). 
CD57 expression is considered a marker of T cell replicative histo-
ry, identifying cells that approach senescence (15, 16). Proportions 
of CD57-expressing memory CD4+ and CD8+ T cells in YATECs 
were variable. On the whole, there was no statistical difference 
between YATECs and age-matched controls. Nonetheless, a num-
ber of YATECs presented levels of CD57-expressing cells equiva-
lent to those found in the elderly group (Figure 2D). Moreover, 
the accumulation of CD57-expressing memory cells in YATECs 
correlated with decreased proportions of naive CD4+ and CD8+ 
T cells (Figure 2E). We observed no significant difference between 
the proportions of regulatory T cells (CD4+CD25hiFoxP3hi) in 
YATECs and age-matched controls, although there was a clear 
trend toward a reduced absolute number in YATECs (which may 
be related to the lower count of CD4+ T cells) (data not shown). 
Of note, YATECs presented higher levels of the proinflammatory 
cytokines IL-1β, IL-8, and eotaxin in the plasma compared with 
age-matched controls (Figure 3). Higher levels of these cytokines 
are evidence of increased inflammation, which usually occurs with 
age. Overall, early thymectomy resulted in a number of immuno-
logical alterations (i.e., reduced T cell counts, skewed distribution 
of T cell subsets, and increased markers of inflammation) that nor-
mally occur later in life.
Normal functional attributes of virus-specific T cells. We next wanted 
to determine the potential impact of early thymectomy on T cell 
qualitative attributes, since they are considered crucial for efficacy 
in infectious or cancerous settings (17, 18). For this purpose, we 
assessed ex vivo phenotypic and functional attributes of exist-
ing virus-specific T cells in YATECs. EBV- or CMV-specific CD8+ 
T cells were identified using a range of tetramers in YATECs in 
order to study their phenotype. These cells displayed regular dif-
ferentiation phenotypes (19, 20) similar to those of controls (i.e., 
predominantly CD27+CD57– [less differentiated] or CD27–CD57+ 
[more differentiated] for EBV- and CMV-specific CD8+ T cells, 
respectively) (Figure 4, A and B). This suggests that thymectomy 
had no apparent impact on the development of memory T cell 
populations specific for persistent viruses. In line with this obser-
vation, we found no difference in terms of STAT5 phosphorylation 
within CD8+ and CD4+ T cells upon stimulation with recombinant 
human IL-2 (rhIL-2) or rhIL-7 between YATECs and controls (data 
not shown), indicating that signaling to homeostatic cytokines 
such as IL-2 or IL-7 is not impaired following thymectomy.
Upon ex vivo stimulation with optimized epitopes, EBV-specific 
CD8+ T cells from YATECs were capable of producing antiviral 
factors normally (Figure 4C). Their polyfunctional profile (i.e., 
simultaneous degranulation and cytokine secretion) did not dif-
fer from those of controls (Figure 4D). Similarly, assessment of 
CMV-specific CD8+ or CD4+ T cell polyfunction after stimulation 
with pp65 or IE1 overlapping peptides revealed no significant dif-
ference between YATECs and controls (Figure 4E). Last, cytokine 
secretion profiles upon stimulation of T cells with the superan-
tigen Staphylococcal enterotoxin B were also similar between 
YATECs and controls (data not shown). Overall, no alteration of 
T cell functional quality was observed, suggesting that T cell effi-
cacy is preserved in the setting of early thymectomy, at least during 
the first 20–25 years of life.
Identification of a subgroup of YATECs with marked alterations of the 
T cell compartment. The involution of the thymus over time is asso-
ciated with a decrease in naive T cell production. Normal donors 
can be readily classified into age groups based on the concomitant 
reduction in naive CD4+ and CD8+ T cell proportions (Figure 5A), 
with individuals over 75 years old being more likely to have less 
than 20% of both naive CD4+ and CD8+ T cells (P = 0.001). On 
the whole, YATECs presented an altered distribution of T cells 
between naive and memory compartments, but variability among 
patients was relatively high, and heterogeneous T cell profiles were 
observed (Figure 2). We identified a subgroup of thymectomized 
donors (n = 8; 32%) with a particularly unbalanced T cell distribu-
tion that is usually characteristic of people over 75 years old (Fig-
ure 5A). Among all YATECs, these donors also had the lowest CD4 
T cell counts (P = 0.03).
The TCR repertoire of sorted CD4+ and CD8+ T cell populations 
from these donors was analyzed by TCR Vβ (TCRBV) spectratype 
analysis (Figure 5B). The analysis revealed a marked reduction in 
diversity within the CD8+ T cell compartment compared with age-
Figure 1
Durable reduction of thymic mass after early thymectomy. Representa-
tive CT scans of the heart region in a 5-year-old child thymectomized 
within 2 weeks of birth and a 5-year-old control subject. Axial and sagit-
tal sections are shown. The arrows indicate the thymus area.
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matched controls or YATECs with mild T cell alteration, with a 
majority of Vβ families affected and clonality indexes drawing near 
those of individuals of old age (Figure 5C). Surprisingly, on the 
whole, only a few CD4+ T cell Vβ families were actually affected, 
indicating that early thymectomy or advanced age had only a mod-
est impact on CD4+ T cell repertoire diversity despite the apparently 
low levels of naive CD4+ T cells. Discrepancy between CD4+ and 
CD8+ T cell oligoclonality (as well as size of the CD57+ subset; see 
Figure 2D), observed in both the YATEC and elderly groups, likely 
reflects the disparate outcome to antigenic stimulation for CD8+ 
versus CD4+ T cells, as described in the literature (21–28). CD8+ 
T cells are known to undergo extensive expansion upon antigenic 
stimulation and then rest to resupply the resting memory CD8+ 
T cell pool. In contrast, antigen-driven expansion of memory CD4+ 
T cells is limited, and fewer CD4+ T cells are able to survive after 
activation, which may be related to an intrinsically lower capac-
ity for survival (29). Overall, this may account for the clear loss of 
TCR repertoire diversity in the CD8+ T cell population (in contrast 
to CD4+ T cells), which reflects the accumulation of oligoclonal 
memory T cell populations in the periphery.
Association with CMV infection. We next aimed to identify factors 
associated with this marked immune alteration in order to provide 
mechanistic insights into its development in some YATECs. All 
YATECs had comparable socioeconomic backgrounds and medi-
cal histories (including standard records of vaccination). Exami-
nation of CT scans from YATECs did not permit us to determine 
whether the development of such altered immune phenotypes 
was influenced by the extent of thymic resection during cardiac 
intervention and the presence of residual thymic tissue. Instead, 
we looked for extrinsic causative factors, which may potentially 
drive the expansion of oligoclonal T cell populations. Interest-
ingly, accumulation of highly differentiated memory CD8+ T cells 
in normal donors has been linked to prior CMV infection (but 
not infection with EBV, varicella-zoster virus, or the attenuated 
measles-mumps-rubella vaccine strains) (30). While 48% of our 
study group was CMV seropositive, in keeping with the normal 
Figure 2
T cell count and subset distribution in thymectomized adults. (A) Absolute counts for CD4+, CD8+ T cells and NK cells in YATECs (median age, 
22.0 years). Counts in young adult (median age, 21.9 years), middle-aged (median age, 35.3 years), and elderly (median age, 82 years) controls 
are shown for comparison. (B) Proportions of naive (CD45RA+CCR7+CD27+) CD4+ or CD8+ T cells in YATECs and young, middle-aged, or 
elderly controls. (C) Proportions of CD31+ naive CD4+ T cells. (D) Proportions of CD57+ cells within memory CD4+ or CD8+ T cells. (E) Correlation 
between naive and CD57+ memory CD4+ or CD8+ T cell percentages in YATECs. The horizontal lines in A–D indicate the median. P values were 
calculated by the Mann-Whitney U test for group comparisons. Spearman’s rank test was used to determine correlations.
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population of this age (51% in our age-matched control group), 
we found a discrepancy between YATECs with mild versus strong 
alterations, with a higher occurrence of CMV seropositivity in 
the latter group (88% vs. 36%; Figure 6A). We then measured the 
magnitude of IFN-γ–producing pp65- or IE1-specific T cells in all 
YATECs in order to get a relative picture of the total frequency of 
CMV-specific T cells (31). The proportions of CMV-specific T cells 
allowed clear discrimination between YATECs with mild versus 
strong alterations (Figure 6, B and C).
These results suggest that the establishment of a strong CMV-
specific T cell response may cause marked alterations of the T cell 
compartment in the context of lack of adequate thymic output. 
In order to further highlight this point, we then considered the 
occurrence of a CMV-specific T cell response as a criteria to com-
pare age-matched controls and YATECs. Despite similar levels of 
IFN-γ–producing CMV-specific (pp65 or IE1) T cells in the 2 groups 
(i.e., CMV-infected YATECs or controls) (Figure 6D), YATECs had 
significantly lower percentages of naive CD4+ or CD8+ T cells (Fig-
ure 6E). Of note, thymectomy or CMV seropositivity alone appeared 
to have an effect on naive T cell proportions, although this was less 
marked than with the combination thymectomy and CMV seropos-
itivity. In addition, we found negative correlations between the lev-
els of both pp65- or IE1-specific T cells and CD4+ and CD8+ naive 
T cell proportions in YATECs (Figure 6F). These observations are in 
line with TCR repertoire diversity in these groups (i.e., considering 
CMV seropositivity). In retrospect, although CMV-seropositive age-
matched controls showed a few oligoclonal Vβ families, the overall 
T cell repertoire diversity was not significantly affected (Figure 5C). 
In contrast, YATECs with significant loss of TCR repertoire diver-
sity were indeed CMV seropositive.
Discussion
The present study shows that young adults who were thymecto-
mized within 2 weeks of birth display a number of immunological 
alterations, including lower CD4+ or CD8+ T cell counts, reduced 
proportions of recent thymic emigrants and naive cells, accumula-
tion of oligoclonal memory T cell populations (including highly 
differentiated CD57+ cells), and increased markers of inflamma-
tion. The occurrence of such changes is normal with age, but it is 
usually observed much later during life. Our results therefore indi-
cate that YATECs can have premature signs of immune aging and 
that the phenomenon of immunosenescence is strongly related 
to the lack of thymic activity and inadequate production of new 
T cells, independently of age. Future studies are needed to gain 
insight into the increase of proinflammatory cytokines in YATECs, 
to understand its relationship to altered homeostasis and a disequi-
librium between lymphocyte subsets in these donors. For instance 
a number of studies suggest a role for regulatory T cells in main-
taining intestinal homeostasis (32). An imbalance between regula-
tory and effector cells may thus affect the control of inflammation 
in the gastrointestinal tract area, potentially leading to the rise of 
proinflammatory markers. It is important to note that the absence 
of thymus appeared to have no adverse consequence on memory 
T cell generation and the functional attributes of antigen specific 
T cells, at least within 20–25 years following thymectomy. This may 
account for the lack of clinical symptoms despite apparent immu-
nological alterations at the level of T cell production in YATECs.
Despite their young age, a number of YATECs (32%) presented 
particularly marked alterations in the T cell compartment that 
are distinctive of individuals older than 75 years. These altera-
tions (i.e., profound imbalance between naive and memory T cell 
proportions, loss of T cell repertoire diversity, evidence of inflam-
mation) are reminiscent of the immune risk phenotype, which 
is defined by gerontologists as a cluster of immune measures 
that are predictive of early all-cause mortality in the elderly (33, 
34). Although all YATECs enrolled in the present study (includ-
ing those with severe immunological alterations) were clinically 
asymptomatic, such phenotype is suggestive of a certain degree of 
immune fragility in this subgroup of YATECs. Of note, recent data 
suggest that thymectomized children present delayed antibody 
responses to tick-borne encephalitis vaccination (35). The demise 
of the thymus in the elderly is considered a major causative factor 
of declining immune competence (2, 36). Moreover, it is known 
that continuous T cell renewal is crucial for the maintenance of 
effective immunity (37). Last, loss of TCR repertoire diversity has 
been shown to contribute to diminished immune responsiveness 
(38, 39). Due to their relatively young age, it is likely that YATECs 
have only been exposed to a limited number of pathogens, against 
which their initial immune resources have been sufficient, so that 
it may be too early to document adverse clinical outcomes. None-
theless, the consequences of thymectomy on patients’ health are 
likely to arise earlier than normally anticipated, in relation to a 
reduced capacity to mount effective adaptive immune responses 
to new pathogens.
The occurrence of such a marked phenotype was directly associ-
ated with the development of a strong T cell response against CMV. 
This finding is in line with data from murine studies suggesting 
that, in the absence of thymic contribution, the pool of naive 
T cells wanes, eventually leaving antigen-experienced T cells to fill 
the immunological space. In these conditions, the T cell repertoire 
is thus shaped by the response (i.e., T cell activation, expansion, or 
death) to antigens (self or foreign) (40–42). In this context, infec-
tion by CMV is particularly relevant: although it is asymptomatic 
in most immunocompetent subjects, it is known to induce a mas-
sive expansion of CMV-specific T cells, reaching up to 40% of total 
T cells during chronic infection (31). This phenomenon is also 
known as memory inflation (43, 44) and was recently shown to be 
Figure 3
Proinflammatory cytokine profile in YATECs. Plasma levels of the 
proinflammatory cytokines IL-1β, IL-8, and eotaxin in YATECs, and 
young adult, middle-aged, or elderly control subjects. The horizontal 
lines indicate the median. P values were calculated using the Mann-
Whitney U test for group comparisons.
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maintained by a continuous replacement of short-lived CMV-spe-
cific T cells through the recruitment of naive T cells in the murine 
CMV infection model (45). Together, these findings indicate that 
in order to cope with the strong pressure imposed by CMV, the 
cellular immune system prematurely exhausts its resources in the 
context of lack of adequate thymic output. Although CMV infec-
tion is usually considered benign, it has been proposed to play an 
important role in the development of immunosenescence (46). 
Our data highlight the impact of this virus on the immune sys-
tem and potential consequences on immune integrity in particu-
lar contexts such as the absence of thymus. This may account at 
least partially for the association between CMV infection and early 
mortality in elderly (47) or for more rapid disease progression in 
HIV co-infected patients (48), settings characterized by a lack of 
adequate T cell renewal.
Importantly, since CMV prevalence is high in the general popu-
lation (50% to 80%), a large number of CHD patients is at risk of 
developing significant immunological alterations. Considerate 
Figure 4
Phenotypic and functional assessment of virus-
specific CD8+ T cells in YATECs. (A) Repre-
sentative staining of CD27 on HLA-A11 EBV 
EBNA-3B AK10–specific CD8+ T cells identified 
in 1 YATEC and 1 control subject. Percentages 
of CD27– or CD27+ cells within tetramer-posi-
tive populations are shown. (B) Expression of 
the differentiation markers CD27 or CD57 on 
EBV- or CMV-specific CD8+ T cells, identified 
using tetramers in YATECs or control individu-
als. Horizontal bars indicate the median. (C) 
Representative example of simultaneous mul-
tifunctional assessment of B8-FL9 EBV–spe-
cific CD8+ T cells from a YATEC patient. Cells 
were stimulated overnight in the presence of 
cognate peptide prior to intracellular staining 
and analysis using 9-color flow cytometry. Per-
centages of cells in the different quadrants are 
shown. Plots are gated on CD3+CD8+ T cells 
and tetramer-positive T cells, respectively. (D) 
Polyfunctional profiling of EBV-specific CD8+ 
T cell populations from YATECs (n = 8) or 
controls (n = 10) upon stimulation with their 
cognate peptide. For simplicity, percentages 
of cells are grouped according to the number 
of functions (from CD107a or CD40L, IFN-γ, 
TNF-α, IL-2, and MIP-1β) elicited in response 
to antigen encounter. Individual segments of 
the pie charts represent the proportions of cells 
within each total population that exhibited the 
number of functions indicated. (E) Polyfunc-
tional profiling of CMV-specific CD8+ or CD4+ 
T cell populations from CMV-seropositive 
YATECs (n = 15) or CMV-seropositive controls 
(n = 15) upon stimulation with pp65 and IE1 
overlapping peptides.
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immune and clinical check-ups of thymectomized CHD patients 
may therefore be advised to monitor the development of an 
immune risk phenotype and potentially related illnesses. More-
over, approaches to boost residual thymic activity and reconstitute 
the naive T cell compartment in thymectomized CHD patients 
may be considered. In this context, IL-7, a cytokine that plays an 
important role in modulating thymic output and the expansion of 
naive and memory cells may represent an interesting perspective 
for YATECs (49, 50). Indeed, recent studies show that administra-
tion of rhIL-7 increases in vivo TCR repertoire diversity through 
the preferential expansion of naive T cells in healthy individuals 
(51) as well as in lymphopenic HIV-infected patients (52, 53). Last, 
surgeons are highly recommended to preserve as much thymic tis-
sue as possible when performing interventions in newborns with 
CHD. The maintenance of thymic activity and T cell diversity is 
necessary to prevent the premature development of an immune 
risk phenotype as these patients age and as pathogens challenge 
their immune system.
Methods
Study subjects and samples.	Blood samples were obtained from 25 young, 
healthy adults (range, 18–26.2 years old; median, 22 years old) who had 
complete removal of the thymus within 15 days of birth during open heart 
surgery due to transposition of great vessels at the Hôpital Necker Enfants 
Malades. Transposition of the great vessels necessitated a single operation, 
and none of the patients enrolled in the study were re-operated. There were 
no records of blood transfusions or additional early childhood illness follow-
ing surgery (e.g., cyanosis). There was no genetic association with transposi-
tion of the great vessels. Thymectomy was performed by total resection of 
both lobes for ease of surgical access to the heart and major vessels. Recent 
thoracic X-ray did not reveal signs of remaining thymic tissue. Rates of hospi-
talization or infection did not differ from the general population of the same 
age. Donors were only included if they had no transplantation, hematologic 
disorders, immunosuppressive or cortisone therapy, or other medications 
known to influence the bone marrow or the immune system. The study was 
approved by the local institutional ethics committee (i.e., Comité de Pro-
tection des Personnes, Hôpital Pitié-Salpêtrière). All participants gave their 
written informed consent. For comparison, blood samples were obtained 
from 29 normal age-matched donors (range, 18.6–25.7 years old; median, 
21.9 years old) and 35 middle-aged (range, 26.4–55 years old; median, 35.3 
years old) or 26 elderly (range, 75–93; median, 82 years old) adults. Elderly 
individuals with malignancies, acute diseases, or advanced stages of severe 
chronic diseases, such as chronic inflammatory disease, atherosclerotic dis-
ease, congestive heart failure, poorly controlled diabetes mellitus, renal, or 
hepatic disease, or chronic obstructive pulmonary disease, as well as indi-
viduals undergoing immunosuppressive therapy were excluded from the 
Figure 5
YATECs with marked alterations of the T cell compartment. (A) Proportions of CD4+ or CD8+ naive T cells in control age groups (open circles, 
young adults; open squares, middle-aged adults; and open diamonds, elderly) and YATECs (filled circles). A subgroup of YATECs with values 
similar to those of the elderly group is indicated by a grey square. Spearman’s rank test was used to determine correlations. (B) Representative 
examples of Vβ family spectratyping analysis performed separately on CD4+ and CD8+ T cell populations from young adult controls, YATECs 
with mild or profound T cell alterations, and elderly controls. Numbers indicate the index of clonality for each Vβ family. (C) Index of clonality 
for all Vβ families are shown in young adult controls (n = 4), YATECs with mild (n = 2) or profound (n = 4) T cell alterations, and elderly controls 
(n = 4). Each symbol represents a single Vβ family. + and – indicate CMV seropositivity. Horizontal bars indicate the median. P values were 
calculated using the Mann-Whitney U test.
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study. Donors were HLA typed and their PBMCs purified. CMV serology was 
performed on plasma samples using a Mastazyme-CMV serology kit (Mast 
Diagnostics) according to the manufacturer’s recommendations.
Reagents. Directly conjugated and unconjugated antibodies were obtained 
from BD Biosciences (CD4 [APC–cyanin 7], HLA-DR [PE–cyanin 7], 
CD25 [PE], CD57 [FITC], CCR7 [PE–cyanin 7], CD38 [APC], CD107a 
[cyanin 5–PE], CD40L [cyanin 5–PE], IFN-γ [Alexa Fluor 700], and TNF-α 
[PE–cyanin 7]); Beckman Coulter (CD45RA [ECD]); Caltag (CD8 [Alexa 
Fluor 405]); eBioscience (Foxp3 [APC]); Dako (CD3 [cascade yellow]); and 
BioLegend (CD27 [Alexa Fluor 700], CD31 [Alexa Fluor 647]). Tetramers 
were produced as previously described (54) and included the following epi-
topes: HLA-A2 CMV pp65-NV9 and IE1-VL9; HLA-A2 EBV BMLF1-GL9 
and BMRF1-YV9; HLA-A11 EBV EBNA-3B AK10; HLA-B7 CMV pp65-
TM10 and pp65-RL11; HLA-B8 CMV IE1-EM9, IE1-EM10, IE1-QV9; 
HLA-B8 EBV BZLF1-RL8, EBNA-3A-FL9 and EBNA-3A-QL9; HLA-B35 
CMV pp65-IY11; and HLA-B35 EBV EBNA-1-YM9, EBNA-3A-HY11 and 
BZLF1-EY11. Measures of the cytokines IL-1β, IL-8, and eotaxin in the 
plasma were performed using multiplex bead immunoassays (Biosource) 
and a Luminex instrument. CMV-overlapping peptides were provided by 
Daniel Olive (Centre Paoli Calmettes, Marseille, France).
Flow cytometry and polyfunctional assessment. Cell surface marker stainings 
were performed as previously described (55). Briefly, titrated tetramers 
Figure 6
Association between CMV-specific T cell responses and marked T cell alterations in YATECs. (A) CMV seropositivity among YATECs with mild 
(n = 17) or strong (n = 8) T cell alterations. Each circle represents one patient. The P value was calculated using the χ2 test. (B) Representative 
stainings for IFN-γ in CD4+ or CD8+ T cells from a CMV-seronegative YATECs or CMV-seropositive YATECs with mild or strong T cell altera-
tions upon stimulation with Staphylococcal enterotoxin B (SEB) or pp65 overlapping peptides. Percentages of IFN-γ+ cells within CD8– or CD8+ 
populations are shown. (C) Percentages of CMV-specific (pp65 and IE1) T cells in YATECs with mild or profound T cell alterations. (D) Percent-
ages of CMV-specific (pp65 and IE1) T cells in CMV-seropositive YATECs or control subjects. (E) Proportions of naive CD4+ or CD8+ T cells 
in YATECs or age-matched control subjects who were CMV seropositive or seronegative. (F) Correlations between percentages of pp65- or 
IE1-specific CD4+ or CD8+ T cells and proportions of naive CD4+ or CD8+ T cells in YATECs. In C–E, horizontal bars indicate the median. In C 
and F, dashed lines indicate the limit of detection. P values were calculated using the Mann-Whitney U test for group comparisons. Spearman’s 
rank test was used to determine correlations.
research article
	 The	Journal	of	Clinical	Investigation   http://www.jci.org   Volume 119   Number 10   October 2009 3077
(tricolor or PE conjugated) were added to 106 PBMCs, followed by the 
addition of a panel of titrated antibodies and incubated for 15 minutes 
at room temperature. To assess functional capacity of EBV-specific CD8+ 
T cells, 106 tetramer-prestained PBMCs were incubated in the presence of 
specific peptide (5 μM) and anti-CD107a antibodies (10 μl) for 1 hour at 
37°C in a 5% CO2 incubator, followed by an additional 15 hours in the 
presence of the secretion inhibitors monensin (2.5 μg/ml; Sigma-Aldrich) 
and Brefeldin A (5 μg/ml; Sigma-Aldrich). Negative controls were obtained 
in the absence of peptide and prestaining with tetramers. BD Cytofix/
Cytoperm was used for permeabilization of the cells prior to staining for 
intracellular cytokines. The percentage frequencies of multifunctional 
cells were calculated within the total population of detectable antigen-spe-
cific CD8+ T cells. To assess functional capacity of CMV-specific CD8+ or 
CD4+ T cells, PBMCs were stimulated with 15-amino-acid-long synthetic 
peptides overlapping by 10 amino acids and spanning the CMV proteins 
pp65 and IE1. Assessment of CD107a was replaced by CD40L in the case 
of CD4+ T cells. The limit of detection for cytokine secretion was 0.01% in 
CD8+ or CD4+ T cell populations. Stainings were analyzed on a LSR2 flow 
cytometer (Becton Dickinson) with appropriate isotype controls and color 
compensation. Data were analyzed using FlowJo v8.2 (Tree Star Inc.) and 
DIVA software. Multifunctional data were analyzed with Pestle and Spice 
(provided by Mario Roederer, Vaccine Research Center, National Institute 
of Allergy and Infectious Diseases, NIH).
TCRBV CDR3 spectratyping. Immunomagnetic sorting of CD8+ and CD4+ 
T cells from PBMCs was performed using MACS technology according to 
the manufacturer’s recommendations (Miltenyi Biotech). The cells were 
added to RLT buffer (RNase Easy Blood Mini kit; Qiagen) with 1% β-mer-
captoethanol for CDR3 spectratyping. cDNA was amplified in 24 separate 
PCR reactions (Vβ families 1–24), each containing 1 specific human Vβ 
subfamily primer coupled with a Cβ primer recognizing the constant BC1 
and BC2 of the β chain, as previously described (56). Data were analyzed 
with Immunoscope 3.1a and ISEApeaks software. The nomenclature of 
TCRBV segments proposed by Arden et al. (57) was used in this study. For 
each subject, we then calculated the index of clonality of each Vβ family as 
the square root of the sum of squares of the normalized area at each peak. 
Thus, indexes of clonality were established for each Vβ family, for each 
donor, and separately for CD4+ and CD8+ T cells.
Statistics. Statistical analysis was performed using GraphPad prism soft-
ware. Data were compared using the Mann-Whitney U test. Spearman’s 
rank test was used to determine correlations. P values at or below 0.05 were 
considered significant.
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